Reverse multidrug resistance in laryngeal cancer cells by knockdown MDR1 gene expression

Journal of Otolaryngology - Head and Neck Surgery

Volumn 38, Issue 4, 2009, Pages 440-448

  Zhigang, Huang ^a   Qi, Zhong ^a   Jugao, Fang ^a   Xiaohong, Chen ^a   Wei, Zhang ^b   Hong, Wang ^b   Hu, Hei ^a   Na, Meng ^b   Zheng, Yang ^a   Demin, Han ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF OTOLARYNGOLOGY   (China)

Author keywords

Genetic vectors; Laryngeal neoplasm; Lentivirus; Multiple drug resistance; Ribonucleic acid interference

Indexed keywords

GLYCOPROTEIN P; LENTIVIRUS VECTOR; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER RESISTANCE; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LARYNX CANCER; LENTIVIRINAE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; LARYNGEAL NEOPLASMS; P-GLYCOPROTEIN;

EID: 70349229361     PISSN: 19160216     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2009.080149     Document Type: Article

References (30)

1. Gan Y, Wientjes MG, Schuller DE, et al. Pharmacodynamics of Taxol in human head and neck tumors. Cancer Res 1996;56:2086-2093 (Pubitemid 26119910)
2. Yusuf RZ, Duan Z, Lamendola DE, et al. Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation. Curr Cancer Drug Targets 2003;3:1-19. (Pubitemid 36119417)
3. Lage H. ABC-transporters: implications on drug resistance from microorganisms to human cancers. Int J Antimicrob Agents 2003; 22:188-199 (Pubitemid 37103199)
4. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, et al. P-glycoprotein: from genomics to mechanism. Oncogene 2003;22:7468-7485
5. Wijnholds J, deLange EC, Scheffer GL, et al. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J Clin Invest 2000;105: 279-285 (Pubitemid 30094447)
6. Mayur YC, Jagadeesh S, Thimmaiah KN. Targeting calmodulin in reversing multidrug resistance in cancer cells. Mini Rev Med Chem 2006;6:1383-1389 (Pubitemid 44890545)
7. Goda K, Fenyvesi F, Bacso Z, et al. Complete inhibition of Pglycoprotein by simultaneous treatment with a distinct class of modulators and the UIC2 monoclonal antibody. J Pharmacol Exp Ther 2007;320:81-88 (Pubitemid 46025722)
8. Kang H, Fisher MH, Xu D, et al. Inhibition of MDR1 gene expression by chimeric HNA antisense oligonucleotides. Nucleic Acids Res 2004;32:4411-4419 (Pubitemid 39232313)
9. Wang H, Chen XP, Qiu FZ. Overcoming multi-drug resistance by anti-MDR1 ribozyme. World J Gastroenterol 2003;9:1444-1449 (Pubitemid 36992330)
10. Liem AA, Chamberlain MP, Wolf CR, et al. The role of signal transduction in cancer treatment and drug resistance. Eur J Surg Oncol 2002;28:679-684
11. Nobili S, Landini I, Giglioni B, et al. Pharmacological strategies for overcoming multidrug resistance. Curr Drug Targets 2006;7:861-879
12. Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391:806-811 (Pubitemid 28099681)
13. Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21- nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494-498 (Pubitemid 32494397)
14. Ma LJ, Han DM, Zhang W, et al. A preliminary study on establishment and characterization of a human laryngeal squamous carcinoma cell line. Arch Otolaryngol Head Neck Surg 2002;9:295-298
15. Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004;117:927-939 (Pubitemid 38798858)
16. Elbashir SM, Harborth J, Weber K, et al. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 2002;26:199-213. (Pubitemid 34969582)
17. Soutschek J, Akinc A, Bramlage B, et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004;432:173-178 (Pubitemid 39545841)
18. Hammond SM, Caudy AA, Hannon GJ. Post-transcriptional gene silencing by double-stranded RNA. Nat Rev Genet 2001;2:110-119 (Pubitemid 33674002)
19. Hua J, Mutch DG, Herzog TJ. Stable suppression of MDR-1 gene using siRNA expression vector to reverse drug resistance in a human uterine sarcoma cell line. Gynecol Oncol 2005;98:31-38
20. Yu JY, Wang TW, Vojtek AB, et al. Use of short hairpin RNA expression vectors to study mammalian neural development. Methods Enzymol 2005;392:186-199
21. Rubinson DA, Dillon CP, Kwiatkowski AV, et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 2003;33:401-406 (Pubitemid 36278858)
22. Lois C, Hong EJ, Pease S, et al. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 2002;295:868-872 (Pubitemid 34118370)
23. Tiscornia G, Singer O, Ikawa M, et al. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Natl Acad Sci U S A 2003;100:1844-1848 (Pubitemid 36254536)
24. Schinkel AH, Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 2003;55:3-29.
25. Nieth C, Priebsch A, Stege A, et al. Modulation of the classical multidrug resistance (MRD) phenotype by RNA interference (RNAi). FEBS Lett 2003;545:144-150
26. Liu C, Qureshi IA, Ding X, et al. Modulation of multidrug resistance gene (mdr-1) with antisense oligodeoxynucleotides. Clin Sci (Lond) 1996;91:93-98 (Pubitemid 26238302)
27. Kowalski P, Wichert A, Holm PS, et al. Selection and characterization of a high-activity ribozyme directed against the antineoplastic drug resistance-associated ABC transporter BCRP/ MXR/ABCG2. Cancer Gene Ther 2001;8:185-192 (Pubitemid 32322258)
28. Wu H, Hait WN, Yang JM. Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells. Cancer Res 2003;63:1515-1519 (Pubitemid 36373637)
29. Nieth C, Priebsch A, Stege A, et al. Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi). FEBS Lett 2003;545:144-150
30. Licht T, Pastan I, Gottesman M, et al. P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells. Ann Hematol 1994;69:159-171 (Pubitemid 24314384)